Navigation Links
JCI early table of contents for April 9, 2012
Date:4/9/2012

EDITOR'S PICK

Moving toward a better treatment for autoimmune diabetes

Insulin is required for the regulation of blood sugar levels. In type I diabetes, the cells that produce insulin are destroyed by the immune system. Chantal Mathieu and colleagues at the University of Leuven have attempted to circumvent this response by taking advantage of the fact that the immune system accepts foreign gut bacteria. The Mathieu group engineered gut bacteria so that they produce a form of insulin, and asked if these bacteria could retrain the immune system in mice with type I diabetes to accept insulin-producing cells. They found that these special bacteria increased the frequency of cured mice when compared to traditional methods alone, with seemingly no undesirable effects. Traditional methods suppress the immune system, which brings with it unfavorable consequences such as increased infections. In fact the Mathieu group confirmed that the immune system functioned in the mice following treatment. Their study provides a promising step towards the ability to reverse type I diabetes, as well as other autoimmune disorders, without incurring adverse side effects.


'/>"/>

Contact: Sarah Jackson
press_releases@the-jci.org
Journal of Clinical Investigation
Source:Eurekalert

Page: 1

Related medicine news :

1. Treat Rheumatoid Arthritis Early and Aggressively: Guidelines
2. Early Study Finds Some Promise for Lung Cancer Vaccine
3. An Early Start for Your Child with Autism
4. New Stool Test Might Aid in Early Detection of Colon Cancer
5. Arteries under pressure early on
6. Early clinical data show galeterone safe, effective against prostate cancer
7. Warm Weather Triggers Early Allergy Season
8. Genetic causes found in nearly 1 in 5 patients with dilated cardiomyopathy heart failure
9. Research gives hope to detecting cancer in early stages
10. Nearly all states have taken action on Affordable Care Acts Patients Bill of Rights
11. Statin Alternative Looks Promising in Early Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... 28, 2015 , ... The 6th Annual Survivor in the City, Chicago ... yet another accolade to its cadre of widespread support—an official letter of support and ... of the medical community and the University of Illinois at Chicago’s Department of Neurosurgery, ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... On May ... Michigan, joined as sponsor of the “Music With A Mission” benefit concert in Mendon, ... the event was to raise money to support music education programs in the underfunded ...
(Date:8/28/2015)... ... August 28, 2015 , ... Loved ... might personally be struggling with chemical dependency, may be able to find some ... a results-driven holistic treatment center for addiction located in Western Michigan. Focusing on ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... of high grade protein with zero fat, carbs, sugar, gluten, lactose or caffeine ... a finalist for the 2015 SupplySide CPG Editor’s Choice Awards. , Five consumer ...
(Date:8/28/2015)... ... August 28, 2015 , ... “ Frequentz ” was featured on ... and coolest applications on the market for iOS, Android, and Windows. Joe Toohey, the ... how this software allows businesses to track product movement from beginning to end. , ...
Breaking Medicine News(10 mins):Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 3Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 2Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 3Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:Track Product Movement from Beginning to End with Frequentz 2
... MVP Health Care, a leading,regional not-for-profit health ... Vermont and New Hampshire, has selected IncentOne, the ... to MVP and,Preferred Care health plan members through ... Care health plans that utilize the "WellStyle Extras",option, ...
... their teachers from four counties, San,Bernardino, Riverside, Inyo and ... Nov. 6 On Sunday, November 9,2008 at 1 ... Stater Bros. Markets, in conjunction with KFRG radio stations ... children on the field,of the Arrowhead Credit Union Stadium ...
... different approaches seek to interfere with mechanisms that inhibit cell ... in the spinal cord and brain can,t be repaired now ... get them to grow again are being proposed by separate ... is to interfere with the built-in mechanisms that prevent nerve ...
... 6 Medicaid Health Plans of,America (MHPA), ... Medicaid health plans, today extended its congratulations ... in becoming the 44th,President of the United ... on his historic,victory," stated MHPA,s Executive Director ...
... Local union outpaces national SEIU in securing rights for ... - Workers at six,Sacramento-area nursing homes voted by more ... Horizon West, achieving important gains,for residents and workers that ... Over 500 members of SEIU United Healthcare Workers-West ...
... Hands Helps Improve Healing, Reduce ... Post-Op Swelling and ... today,the release of its breakthrough Hand Wrap for use with ... Wrap,dramatically increases physicians, and patients, treatment options by,extending Game Ready,s ...
Cached Medicine News:Health News:MVP Health Care and IncentOne Partner to Provide Member Incentives for MVP and Preferred Care 'WellStyle Extras' Program 2Health News:Stater Bros. Charities, KFRG Radio Stations and Loma Linda University Children's Hospital Will Present More Than 1,100 Brand-New Bikes to 4th Grade Students! 2Health News:New Pathways Studied to Repair Nerves 2Health News:New Pathways Studied to Repair Nerves 3Health News:United Healthcare Workers Win New Contract with Horizon West 2Health News:United Healthcare Workers Win New Contract with Horizon West 3Health News:Game Ready(TM) Announces New Hand Treatment 2
(Date:8/28/2015)... , Aug. 28, 2015 Patterson Medical, ... (Nasdaq: PDCO ), is now an independent ... acquisition of Patterson Medical by Madison Dearborn Partners ... its name for a transition period before rebranding ... and sports medicine products.  With the focused resources ...
(Date:8/28/2015)... , Aug. 28, 2015 ... announced the addition of the "Investigation Report ... their offering. Developed by AstraZeneca plc, ... an important drug for the treatment of schizophrenia. ... quetiapine was listed in the Catalogue of Drugs ...
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Investigation Report on ... their offering. Developed by Novo Nordisk, ... is an important drug for the treatment of ... a fast- acting insulin analog, starts working fast ...
Breaking Medicine Technology:Patterson Medical Positioned for Continued Growth as a Newly Independent Company 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 3China Quetiapine Market Investigation Report 2010-2019 2China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2
... -- Peregrine,s Second Phase II Bavituximab Cancer Trial Is Evaluating the, ... ... Paclitaxel --, TUSTIN, Calif., June 30 Peregrine,Pharmaceuticals, Inc. ... in a Phase II trial designed to evaluate the safety,and efficacy of ...
... Meeting with FDA Set for Sept. 29, ... (Nasdaq: TPTX ) today announced that data ... American Headache Society showed that, in,addition to meeting ... two,hours, the company,s lead AMPA/kainate-type glutamate receptor antagonist,tezampanel, ...
Cached Medicine Technology:Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 2Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 3Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 4Data Presented at American Headache Society's Annual Scientific Meeting Show Primary Endpoint Met as Well as Improvement on Important Secondary Endpoints in Phase IIb Acute Migraine Trial of TorreyPines Therapeutics' Tezampanel 2Data Presented at American Headache Society's Annual Scientific Meeting Show Primary Endpoint Met as Well as Improvement on Important Secondary Endpoints in Phase IIb Acute Migraine Trial of TorreyPines Therapeutics' Tezampanel 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: